Manufacturer record

Preet Remedies Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

7 batches manufactured by Preet Remedies Ltd (Himachal Pradesh) were declared Not of Standard Quality between November 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: MPR-251105, Levocetirizine Dihydrochloride 5mg Tablets IP (exp Oct 2027). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample is not of standard quality for the reason stated under "Description" of the tablets. Listed in the September 2026 alert.

Records by type

7 records linked to Preet Remedies Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
7Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Nov 2019 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

7
NSQ batches since 2019
6
Products affected
Assay
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2019 · 12022 · 12023 · 22025 · 12026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Levocetirizine Dihydrochloride 5mg Tablets IP Batch MPR-251105Mfg Nov 2025 · Exp Oct 2027 The sample is not of standard quality for the reason stated under "Description" of the tablets.Description RDTL, GuwahatiCDSCO lab Sep 2026
Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP (500mg/2mg) Batch PRT-250229Mfg Feb 2025 · Exp Jan 2027 DescriptionDescription DTL, Bengaluru, KarnatakaState lab Jun 2026
Metformin Hydrochloride Prolonged Release and Glimepiride Tablets I.P (500mg/2mg) Batch PRT-250235Mfg Feb 2025 · Exp Jan 2027 Dissolution test for GlimepirideDissolution RDTL, Bellary, KarnatakaState lab Nov 2025
Amoxycillin, Cloxacillin & Lactic Acid Bacillus Capsules (MoxiSpin�-D) Batch SPL-220225Mfg Feb 2022 · Exp Jan 2024 Assay of CloxacillinAssay RDTL GuwahatiState lab Apr 2023
Amoxycillin, Cloxacillin & Lactic Acid Bacillus Capsules Amoxynol Plus LB Batch PRB-220203Mfg Feb 2022 · Exp Jan 2024 Assay of CloxacillinAssay RDTL GuwahatiState lab Mar 2023
Ofloxacin and Ornidazole Tablets IP (Ofoxo-OZ Tablet) Batch KHP-201218Mfg Dec 2020 · Exp Nov 2022 DissolutionDissolution RDTL GuwahatiState lab Jul 2022
Cadpril 5 (Ramipril Tablets I.P) Batch ZPR0037Mfg Aug 2018 · Exp Jul 2020 AssayAssay CDL KolkataCDSCO lab Nov 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.